Clinical Trials
9
Active:1
Completed:5
Trial Phases
2 Phases
Phase 1:1
Not Applicable:8
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (88.9%)Phase 1
1 (11.1%)NT-II™ Collagen for Joint Discomfort and Function
Not Applicable
Not yet recruiting
- Conditions
- Activity-Related Knee DiscomfortJoint DiscomfortFunctional Joint PainFunctional Knee PainKnee Acute and Chronic Pain
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Hofseth Biocare ASA
- Target Recruit Count
- 120
- Registration Number
- NCT07119645
Change in Omega 3 Index in Healthy Adults with OmeGo or a Standard Omega-3 Oil Supplement
Not Applicable
Recruiting
- Conditions
- Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Hofseth Biocare ASA
- Target Recruit Count
- 96
- Registration Number
- NCT06802068
- Locations
- 🇺🇸
Alethios, Menlo Park, California, United States
🇺🇸Alethios, Inc., San Francisco, California, United States
Investigating the Effect of Daily CARDIO® Capsules Supplementation on Improved Sleep in Healthy, Urban-Dwelling Adults
Not Applicable
Completed
- Conditions
- SleepPollution; ExposureCough
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Hofseth Biocare ASA
- Target Recruit Count
- 131
- Registration Number
- NCT06768970
- Locations
- 🇺🇸
Alethios, Inc., San Francisco, California, United States
Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics
Not Applicable
Completed
- Conditions
- Asthma
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Hofseth Biocare ASA
- Target Recruit Count
- 70
- Registration Number
- NCT05137132
- Locations
- 🇳🇴
Hofseth Biocare ASA, Ålesund, More And Romsdal, Norway
Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease
Not Applicable
Not yet recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Hofseth Biocare ASA
- Target Recruit Count
- 100
- Registration Number
- NCT05130294
- Locations
- 🇳🇴
Hofseth Biocare ASA, Ålesund, More And Romsdal, Norway
- Prev
- 1
- 2
- Next
News
No news found